ISPH Insider Trading Activity and SEC Form 4 Filings
ISPH insider trading summary
No open-market insider purchases or sales of Inspire Pharmaceuticals Inc (ISPH) have been reported on SEC Form 4 in the past 12 months.
Latest ISPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 15, 2010 | Kip Frey | Director | Sell | $610 (83 @ $7.34) |
| Nov 15, 2010 | Kip Frey | Director | Sell | $3K (400 @ $7.34) |
| Nov 15, 2010 | Kip Frey | Director | Sell | $1K (198 @ $7.26) |
| Nov 15, 2010 | Kip Frey | Director | Sell | $7K (996 @ $7.27) |
| Nov 15, 2010 | Kip Frey | Director | Sell | $17K (2,306 @ $7.28) |
| Nov 15, 2010 | Kip Frey | Director | Sell | $25K (3,434 @ $7.25) |
| Nov 15, 2010 | Kip Frey | Director | Sell | $4K (517 @ $7.33) |
| Nov 9, 2010 | Nancy J Hutson | Director | Buy | $38K (5,400 @ $6.99) |
| Nov 9, 2010 | Nancy J Hutson | Director | Buy | $11K (1,600 @ $6.98) |
| May 3, 2010 | Benjamin R Yerxa | EVP & Chf, Research & Develop | Sell | $2K (300 @ $6.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.